Jan 30 2024

Expertise of the month

Expertise of the month: Identification of a sustainable route for faster and cheaper development

Due to the time or budget constraints, process development is often underestimated at the early development phases, slowing down and jeopardizing high-value projects. At SpiroChem, thanks to our in-depth understanding of drug development challenges, we recommend and offer Early Route Scouting that guarantees smoother, safer, faster and more cost-effective scale-up from pre-clinical studies, paving the way for clinical development and market.

Classical way with short-term benefits

The MedChem route:

is never really questioned
is felt to be fit-for-purpose and developing it to be a lower risk

The short-term benefits:

consist of putting just about enough FTEs for quick fixes
don’t preclude longer term risks at the most time-critical part
of your clinical development

Do you want to avoid:

supply delays at the most time-critical stage of your clinical development?
refiling for regulatory submissions because of a necessary late-stage
synthetic route change?

The way to go with long-term benefits

The earlier a robust route is designed and developed, the shorter the overall time and the lesser the investments until process validation and registration.

SpiroChem helps you to be prepared to ensure:

Smooth scale-up from GLP-Tox batches to GMP batches
No disruptions from discovery to market

Save time and money for your project by investing early in Route Scouting at SpiroChem.

Back to all

Previous Next